COVID-19 Business Resources

COVID-19 Business Resources

With daily updates about the economic impact of the Coronavirus (COVID-19) on businesses and questions about the relief offered by the European Commission, EU member states and U.S. Government agencies, EACC has put together an overview of state and federal relief available to offset economic losses.

American & European businesses are facing an unprecedented economic disruption due to the COVID-19 outbreak government worldwide have put together various loan programs to help those businesses.

This section offers resources from the US and across Europe to help you navigate this “new normal.”

We also added a selection of COVID-19 related member insights and resources. Please feel free to reach out to the EACCNY Office if you would like to connect to any of the EACC members to learn more about any of the issues raised in their articles and white papers.

NEED MORE HELP :
If you have questions or need assistance applying for the above relief programs, we encourage you to reach out to the EACC. We have a network of experts at the ready who can help you through the process and manage the labyrinth of paperwork. You can reach us by email at ybr[at]eaccny.com.

COVID-19 RELATED NEWS

COVID-19 News, Member News

Thompson Hine | Government Measures Taken in Response to COVID-19: Country-by-Country Guide 2.0

Since April 2020, we have collaborated with our foreign law firm partners to provide a chart summarizing the economic, labor and employment, health and safety, and export and import measures taken by governments around the world in response to the COVID-19 pandemic. After a short break, we are back with version 2.0 of our chart with substantive changes to reflect the most pressing and interesting government measures concerning the COVID-19 pandemic. The new version of the chart includes a concise, corporate-focused...

Read more

COVID-19 News, Member News

EIB | BioNTech moves to head of pack in fight against coronavirus

EU financing for COVID-19 vaccine helps German firm close in on a solution with highly effective trial results When Özlem Türeci and her husband, Uğur Şahin, announced that the COVID-19 vaccine developed by their company, BioNTech, had excellent results in its latest tests, the couple took a short break from their round-the-clock research schedule. But only long enough to drink a cup of tea. “It was oolong tea to be precise,” Türeci says. “We both like it and it’s easy to...

Read more

Chapter News, COVID-19 News

Coronavirus: EU Commission approves contract with CureVac to ensure access to a potential vaccine

Today, the European Commission approved a fifth contract with the European pharmaceutical company CureVac, which provides for the initial purchase of 225 million doses on behalf of all EU Member States, plus an option to request up to a further 180 million doses, to be supplied once a vaccine has proven to be safe and effective against COVID-19. Today's contract with CureVac enlarges the already broad portfolio of vaccines to be produced in Europe, including the contracts signed with AstraZeneca, Sanofi-GSK, Janssen Pharmaceutica...

Read more

Chapter News, COVID-19 News

EU Commission disburses €14 billion under SURE to nine Member States

The European Commission has disbursed €14 billion to nine EU countries in the second installment of financial support to Member States under the SURE instrument. As part of today's operations, Croatia has received €510 million, Cyprus €250 million, Greece €2 billion, Italy an additional €6.5 billion, Latvia €120 million, Lithuania €300 million, Malta €120 million, Slovenia €200 million and Spain an additional €4 billion. This support, in the form of loans granted on favourable terms, will assist these Member States...

Read more